A semi-synthetic macrolide antibiotic in which the erythronolide A lactone ring has been altered to prevent inactivation in the gastric milieu; active against Gram-positive and Gram-negative cocci, Gram-positive bacilli, and some Gram-negative bacilli without significantly affecting the fecal flora.